

Health Library
October 10, 2025
Question on this topic? Get an instant answer from August.
I-Erlotinib iyimithi yomdlavuza eqondiwe esiza ukulwa nezinhlobo ezithile zomdlavuza wamaphaphu nomdlavuza wendlala yamanyikwe. Le mithi edliwa ngomlomo isebenza ngokuvimba amaprotheni athile asiza amaseli omdlavuza ukuthi akhule futhi asakazeke emzimbeni wakho wonke.
Uma udokotela wakho ekunikeze i-erlotinib, cishe unemibuzo mayelana nokuthi isebenza kanjani nokuthi yini ongayilindela. Ake sihambe kukho konke okudingeka ukwazi ngale ndlela ebalulekile yokwelapha umdlavuza ngamagama alula, acacile.
I-Erlotinib iyimithi kadokotela eyingxenye yeqembu lezidakamizwa ezibizwa ngokuthi ama-tyrosine kinase inhibitors. Cabanga ngayo njengokwelashwa okuqondiwe okuhlasela ngqo amaseli omdlavuza ngenkathi izama ukonga amaseli akho anempilo.
Le mithi iza njengamaphilisi owathatha ngomlomo kanye ngosuku. Ngokungafani ne-chemotherapy yendabuko ethinta izinhlobo eziningi zamaseli, i-erlotinib igxila ekuvimbeni izimpawu ezithile ezidingwa amaseli omdlavuza ukuze asinde futhi aphindaphindeke.
Lo muthi waklanywa ngqo ukuthi uqondise imidlava ezinoshintsho oluthile lofuzo, okwenza kube yindlela yokwelapha enembile. Udokotela wakho ngokuvamile uzohlola amaseli akho omdlavuza ngaphambi kokukuchazela i-erlotinib ukuze aqiniseke ukuthi yikho okulungile esimweni sakho esithile.
I-Erlotinib isetshenziselwa ikakhulukazi ukwelapha izinhlobo ezimbili eziyinhloko zomdlavuza. Udokotela wakho uyikuchazela uma ezinye izindlela zokwelapha zingasebenzanga noma uma umdlavuza wakho unezimpawu ezithile zofuzo ezenza i-erlotinib ibe yimpumelelo.
Ukusetshenziswa okuvame kakhulu kungokomdlavuza wamaphaphu ongawona amancane, ikakhulukazi uma umdlavuza ususabalale kwezinye izingxenye zomzimba wakho. I-Erlotinib isebenza kahle kakhulu emidlavuzeni yamaphaphu enoshintsho kuprotheni ebizwa nge-EGFR (epidermal growth factor receptor).
Umuthi futhi usetshenziselwa ukwelapha umdlavuza wamanyikwe, ngokuvamile ngokuhlangana nomunye umuthi obizwa nge-gemcitabine. Kulokhu, i-erlotinib isiza ukunciphisa ukukhula komdlavuza futhi ingakusiza ukuthi uzizwe ungcono isikhathi eside.
Ngezinye izikhathi odokotela banquma i-erlotinib njengokwelashwa kokuqala, okusho ukuthi ngomunye wemithi yokuqala ozoyizama. Ngezikhathi ezithile, isetshenziswa ngemuva kokuthi ezinye izindlela zokwelapha umdlavuza ziyekile ukusebenza ngempumelelo.
I-Erlotinib isebenza ngokuvimba iphrotheni ethile ebizwa nge-EGFR ehlala ebusweni bamaseli omdlavuza. Le phrotheni ngokuvamile ithola amasignali atshela amaseli omdlavuza ukuthi akhule futhi ahlukaniswe ngokushesha.
Lapho i-erlotinib ivimba lezi zimpawu, kufana nokunqamula uhlelo lokuxhumana olusetshenziswa amaseli omdlavuza ukuze asinde. Ngaphandle kwalezi zimpawu zokukhula, amaseli omdlavuza awakwazi ukuzala ngokushesha, futhi amaningi awo ekugcineni azofa.
Lo muthi uthathwa njengokwelashwa komdlavuza okulinganiselwe. Ngokuvamile akubi emzimbeni wakho kunamakhemikhali endabuko, kodwa usawumuthi onamandla odinga ukuqashwa ngokucophelela yithimba lakho lezempilo.
Indlela eqondiwe isho ukuthi i-erlotinib ingasebenza kahle omdlavuzeni ofanele, kodwa ngeke isebenze kuyo yonke imidlavuza. Yingakho udokotela wakho edinga ukuhlola amaseli akho omdlavuza kuqala ukuze abone ukuthi anawo yini amagoli athile angahlaselwa yi-erlotinib.
Kufanele uthathe i-erlotinib esiswini esingenalutho, okungenani ihora elilodwa ngaphambi kokudla noma amahora amabili ngemuva kokudla. Ukuyithatha nokudla kunganciphisa ngempela ukuthi umzimba wakho uyimunca kahle kangakanani imithi.
Indlela engcono kakhulu ukuthatha umthamo wakho wansuku zonke ngesikhathi esifanayo nsuku zonke ngenkomishi yamanzi egcwele. Abantu abaningi bakuthola kuwusizo ukuthatha i-erlotinib ekuseni, bese belinda ihora ngaphambi kokudla isidlo sasekuseni.
Uma unenkinga yokugwinya ithebhulethi, ungangiyeka emanzini acishe abe yingxenye yenkomishi. Vusa ingxube bese uyiphuza ngokushesha, bese ugeza ingilazi ngamanzi amaningi bese uphuza naleyo futhi ukuze uqiniseke ukuthi uthola umthamo ogcwele.
Gwema ama-grapefruit nejusi le-grapefruit ngenkathi uthatha i-erlotinib, ngoba lokhu kungaphazamisa indlela umzimba wakho oqhubula ngayo imithi. Udokotela wakho uzokunikeza imiyalelo ethile mayelana nanoma yikuphi okunye ukudla noma iziphuzo okufanele ukugweme.
Ubude bokwelashwa nge-erlotinib buhluka kakhulu kumuntu nomuntu futhi kuncike ekutheni imithi isebenza kahle kangakanani kuwe. Abanye abantu bayayithatha izinyanga, kanti abanye bangayithatha iminyaka.
Udokotela wakho uzoqapha umdlavuza wakho njalo ngokuskena nokuhlolwa kwegazi ukuze abone ukuthi usabela kanjani ekwelashweni. Uma nje imithi isiza ukulawula umdlavuza wakho futhi ulawula kahle imiphumela emibi, cishe uzoqhubeka nokuyithatha.
Uma umdlavuza wakho uqala ukukhula futhi noma uma uba nemiphumela emibi engathi sína, udokotela wakho angase anqume ukuyeka i-erlotinib noma akushintshele ekwelashweni okuhlukile. Lokhu akusho ukuthi imithi yehlulekile - kuvamile ukuthi ukwelashwa komdlavuza kusebenze isikhashana bese kudingeka ukulungiswa.
Ungayeki ukuthatha i-erlotinib ngokuzumayo ngaphandle kokukhuluma nodokotela wakho kuqala. Noma ngabe uzizwa ungcono, imithi ingase isasebenza ukugcina umdlavuza wakho ulawulwa.
Abantu abaningi bathola eminye imiphumela emibi nge-erlotinib, kodwa eminingi yayo ingalawulwa ngokunakekelwa okufanele nokuqapha. Izindaba ezinhle ukuthi imiphumela emibi engathi sína ayivamile njengoba kunjalo ngamakhemikhali endabuko.
Nawa imiphumela emibi evame kakhulu ongase uyithole:
Ukuqubuka kwesikhumba kuvamile ikakhulukazi futhi kuvame ukuvela njengamaqhubu amancane, afana namabala ebusweni bakho nasemzimbeni ongenhla. Ngenkathi kungase kungakhululeki, lokhu kuqubuka kungase kube yisibonakaliso sokuthi imithi isebenza ngempumelelo.
Imiphumela emibi engavamile kodwa ebucayi ingabandakanya izinkinga zokuphefumula, isifo sohudo esibi esiholela ekuphelelwe amanzi emzimbeni, noma izinkinga zesibindi. Udokotela wakho uzokuqapha ngokucophelela lezi zinkinga ngokuhlolwa okuvamile kanye nokuhlolwa kwegazi.
Uma uba nanoma yiziphi izimpawu ezikhathazayo, ikakhulukazi ubunzima bokuphefumula, ubuhlungu obukhulu besisu, noma izimpawu zokuphelelwa amanzi emzimbeni, xhumana nethimba lakho lezempilo ngokushesha. Imiphumela eminingi emibi ingalawulwa ngempumelelo uma itholwe kusenesikhathi.
I-Erlotinib ayifanele wonke umuntu, futhi udokotela wakho uzobukeza ngokucophelela umlando wakho wezokwelapha ngaphambi kokuyinika. Umuthi udinga ukusebenza kwesibindi okunempilo kanye nekhono lokubekezelela imiphumela yawo emibi.
Akufanele uthathe i-erlotinib uma ukhulelwe noma uhlela ukukhulelwa, ngoba ingalimaza umntwana ongakazalwa. Abesifazane abangakhulelwa kufanele basebenzise izindlela zokulawula inzalo ezisebenzayo ngesikhathi sokwelashwa kanye okungenani inyanga eyodwa ngemva kokuyeka umuthi.
Abantu abanezifo zesibindi ezinzima noma izimo ezithile zamaphaphu kungenzeka bangabi ngabazali abahle be-erlotinib. Udokotela wakho uzokwenza izivivinyo zokuhlola ukusebenza kwesibindi sakho nempilo yonke ngaphambi kokuqala ukwelashwa.
Uma usebenzisa eminye imithi ethile, ikakhulukazi imithi yokunciphisa igazi noma ama-antibiotics athile, udokotela wakho angase adinge ukulungisa uhlelo lwakho lokwelapha. Hlala utshela ithimba lakho lezempilo ngayo yonke imithi, izithasiselo, nemikhiqizo yezitshalo oyithathayo.
I-Erlotinib yaziwa kakhulu ngegama layo lomkhiqizo elithi Tarceva. Leli yigama lomkhiqizo lokuqala lapho imithi yaqala ukugunyazwa futhi isasetshenziswa kakhulu namuhla.
Ungase futhi uhlangane nezinhlobo ze-generic ze-erlotinib, eziqulathe isithako esifanayo esisebenzayo kodwa ezingase zibe nezithako ezingasebenzi ezihlukene. Izinhlobo ze-Generic ngokuvamile zishibhile kodwa zisebenza ngempumelelo njengohlobo lomkhiqizo.
Noma ngabe uthola i-Tarceva yomkhiqizo noma i-erlotinib ejwayelekile ngokuvamile kuncike ekuhlinzekweni kwakho komshuwalense kanye nezintandokazi zekhemisi. Zombili lezi zinhlobo zihlangabezana namazinga afanayo ekhwalithi nokuphepha asethwe yizinhlangano ezilawulayo.
Eminye imithi eminingi isebenza ngendlela efanayo ne-erlotinib ekwelapheni umdlavuza wamaphaphu nowendlala yamanyikwe. Udokotela wakho angase acabangele lezi ezinye izindlela uma i-erlotinib ingasebenzi kahle noma uma uhlangabezana nemiphumela emibi enzima.
Umdlavuza wamaphaphu, ezinye izindlela zihlanganisa ezinye izindlela zokwelapha eziqondiwe njenge-gefitinib (Iressa), afatinib (Gilotrif), noma osimertinib (Tagrisso). Ngamunye wale mithi uqondisa izici ezihlukene zokukhula kweseli lomdlavuza.
Umdlavuza wendlala yamanyikwe, izinketho zokwelapha zingabandakanya inhlanganisela ehlukene ye-chemotherapy noma ezinye izindlela zokwelapha eziqondiwe. Ukukhetha kuncike ohlotsheni lwakho oluthile lomdlavuza, impilo yonke, kanye nokwelashwa kwangaphambilini okutholile.
Imithi ye-Immunotherapy nayo iba ezinye izindlela ezivamile zezinhlobo ezithile zomdlavuza wamaphaphu. Udokotela wakho we-oncologist uzosiza ekunqumeni ukuthi iyiphi indlela yokwelapha enikeza ibhalansi engcono kakhulu yokusebenza kahle nemiphumela emibi elawulekayo esimweni sakho.
Kokubili i-erlotinib ne-gefitinib ziyizindlela zokwelapha ezihloswe ngqo zomdlavuza wamaphaphu, kodwa zisebenza ngendlela ehlukile kancane futhi zingase zifaneleke kangcono ezimweni ezihlukene. Ukukhetha phakathi kwazo kuncike ezicini zomdlavuza wakho kanye nezici zomuntu ngamunye.
Ucwaningo lubonise ukuthi zombili le mithi ingasebenza kahle ngokulinganayo ekwelapheni umdlavuza wamaphaphu we-EGFR-positive. Nokho, i-erlotinib ingasebenza kangcono kwabanye abantu, kuyilapho i-gefitinib ingase ifaneleke kangcono kwabanye.
Amaphrofayili emiphumela emibi afana phakathi kwale mithi, nakuba abanye abantu bekwazi ukubekezelela enye kangcono kunenye. I-Erlotinib ithathwa kanye ngosuku, kuyilapho i-gefitinib nayo ithathwa kanye ngosuku, okwenza kube lula ngokulinganayo.
Udokotela wakho uzocabangela izici ezinjengokwakheka kwezakhi zofuzo zomdlavuza wakho, impilo yakho yonke, eminye imithi oyithathayo, kanye nezintandokazi zakho siqu lapho ukhetha phakathi kwalezi zinketho. Akukho okukhethwa “okungcono” emhlabeni wonke - okungcono kuphela esimweni sakho esithile.
I-Erlotinib ngokuvamile ingasetshenziswa ngokuphepha kubantu abanezifo zenhliziyo, kodwa idinga ukuqapha okucophelelayo. Imithi ngokuvamile ayibangeli izinkinga zenhliziyo eziqondile, kodwa eminye imiphumela emibi efana nohudo nokuphelelwa amanzi emzimbeni kungase kube nomthelela enhliziyweni yakho uma iba nzima.
Udokotela wakho uzobuyekeza impilo yakho yenhliziyo ngaphambi kokuqala i-erlotinib futhi akuqaphe eduze ngesikhathi sokwelashwa. Uma unezimo zenhliziyo ezikhona, qiniseka ukuthi udokotela wakho we-oncologist uyazazi futhi uhlele nodokotela wakho wenhliziyo njengoba kudingeka.
Uma ngengozi uthatha i-erlotinib eningi kunaleyo ebekiwe, xhumana nodokotela wakho noma isikhungo sokulawula ubuthi ngokushesha. Ukuthatha okuningi kungakhuphula ingozi yakho yemiphumela emibi engathi sína, ikakhulukazi uhudo olukhulu nokusabela kwesikhumba.
Ungazami ukulungisa umthamo owengeziwe ngokuqaqa umthamo wakho olandelayo. Kunalokho, landela imiyalelo kadokotela wakho mayelana nokuthi uzobuyela nini esimisweni sakho esijwayelekile sokuthatha imithi. Gcina umkhondo walokho okwenzekile ukuze ukwazi ukuxoxa ngakho nethimba lakho lezempilo.
Uma uphuthelwa umthamo we-erlotinib, yithathe ngokushesha lapho ukhumbula, uma nje kungamahora okungenani angu-12 ngaphambi komthamo wakho olandelayo ohleliwe. Uma sekuseduze nesikhathi somthamo wakho olandelayo, weqa umthamo ophuthelwe bese uqhubeka neshejuli yakho ejwayelekile.
Ungalokothi uthathe imithamo emibili ngesikhathi esisodwa ukuze ulungise umthamo ophuthelwe. Lokhu kungandisa ingozi yakho yemiphumela engemihle ngaphandle kokuhlinzeka ngenzuzo eyengeziwe. Uma uvame ukukhohlwa imithamo, cabangela ukusetha i-alamu yansuku zonke noma usebenzise umhleli wamaphilisi ukukusiza ukuthi ukhumbule.
Kufanele uyeke kuphela ukuthatha i-erlotinib lapho udokotela wakho ekutshela ukuthi kufanelekile ukwenza kanjalo. Lesi sinqumo ngokuvamile sisekelwe ekutheni umuthi ukulawula kahle kangakanani umdlavuza wakho nokuthi uyithola kanjani imiphumela engemihle.
Udokotela wakho uzohlola njalo impendulo yakho ekwelashweni ngokuskena nokuhlolwa kwegazi. Uma umdlavuza wakho uqhubeka ngaphandle kwe-erlotinib, noma uma uthola imiphumela engemihle engalawuleki, udokotela wakho uzoxoxa ngokuyeka umuthi futhi ahlolisise ezinye izindlela zokwelapha.
Ngokuvamile kungcono ukukhawulela ukusetshenziswa kotshwala ngenkathi uthatha i-erlotinib, njengoba utshwala bungandisa ingozi yezinkinga zesibindi futhi bungase luqhubeke nemiphumela engemihle ethile efana nesicanucanu nokukhathala. Amanani amancane otshwala ngokuvamile alungile, kodwa xoxa ngesimo sakho esithile nodokotela wakho.
Uma ukhetha ukuphuza ngezikhathi ezithile, qapha ukuthi uzizwa kanjani futhi uqaphele ukuthi utshwala bungakwenza uzwe imiphumela engemihle ye-erlotinib. Udokotela wakho angakunikeza isiqondiso esiqondene nawe esisekelwe empilweni yakho yonke kanye nempendulo yokwelashwa.
Get clear medical guidance
on symptoms, medications, and lab reports.